The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20072327
Guo et al.

Figure S1 Expression of early developmental markers in fresh splenic p110δD910A/D910A NK cells.

Figure S2 IL-2–activated NK cells from p110δD910A/D910A mice express normal levels of developmental or activation markers.

Figure S3 Catalytic inactivation of p110δ does not affect the expression of self–MHC class I molecules.

Figure S4 Cell death is not the cause of reduced numbers of Ly49C/I subsets in p110δD910A/D910A mice.

Figure S5 Cytotoxicity of NK cells against EL4H60 is primarily mediated by NKG2D receptor.

Figure S6 NK cells from p110δD910A/D910A mice have a decreased ability to clear tumor cells in vivo.

Figure S7 Ability of IL-2–activated, BM-derived NK cells from p110δD910A/D910A mice to generate cytokines or chemokines is severely impaired.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS